Background While it is now apparent clinical sequelae (long COVID) may persist after acute
COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to …

Objective To appraise the availability, quality, and inclusivity of clinical guidelines produced
in the early stage of the coronavirus disease 2019 (covid-19) pandemic. Design Rapid …

Background Monkeypox (MPX) is an important human Orthopoxvirus infection. There has
been an increase in MPX cases and outbreaks in endemic and non-endemic regions in recent …

Background Chikungunya virus (CHIKV) has expanded its geographical reach in recent
decades and is an emerging global health threat. CHIKV can cause significant morbidity and …

The Sudan virus disease outbreak in Uganda in 2022 showed our vulnerability to viral
haemorrhagic fevers (VHFs). Although there are regular outbreaks of VHFs with high morbidity …

Background The COVID-19 pandemic has highlighted the importance of evidence-based
clinical decision-making. Clinical management guidelines (CMGs) may help reduce morbidity …

Background: Clinical management guidelines (CMGs) can be useful tools to guide clinician’s
decision making and enable consistent evidence-based high-quality care. Here, we …

Background The clinical sequelae (Long Covid) of acute Covid-19 are recognised globally,
yet the risk of developing them is unknown. Methods A living systematic review (second …

Background: Conducting and implementing clinical research response during pandemic and
epidemic diseases outbreaks are often fraught with challenges due to their unprecedented …

Objective To assess the responsiveness and quality of clinical management guidelines (CMGs)
in SARS, MERS and COVID-19 and determine whether this has improved over time. …